modified TOMOX-HAIC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for modified TOMOX-HAIC, covering 2024-02-29 to 2024-02-29. Get the full timeline:
Most recent: Clinical Trial Update: Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma [Phase 2]